{
  "image_filename": "table_p2_det_1_011.png",
  "image_path": "FlublokPI/extracted/figures/table_p2_det_1_011.png",
  "image_type": "Table",
  "page_number": 2,
  "block_id": "det_1_011",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "A table summarizing the percentage of solicited local and systemic adverse reactions in a clinical trial, comparing Flublok (N=2272) to Placebo (N=2231), with categories such as pain, redness, swelling, headache, fatigue, muscle pain, etc. The table compares Flublok to placebo and does not include any data or mention of Fluarix, so it does not support the claim. Note: Analysis limited to the visible table; no reference to Fluarix is shown on this page.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table summarizing the percentage of solicited local and systemic adverse reactions in a clinical trial, comparing Flublok (N=2272) to Placebo (N=2231), with categories such as pain, redness, swelling, headache, fatigue, muscle pain, etc.",
    "evidence_found": null,
    "reasoning": "The table compares Flublok to placebo and does not include any data or mention of Fluarix, so it does not support the claim.",
    "confidence_notes": "Analysis limited to the visible table; no reference to Fluarix is shown on this page."
  }
}